Massage Application and Motor Performance, Stress Assessment in Premature Babies
Launched by MUSTAFA KEMAL UNIVERSITY · Oct 4, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how infant massage can impact the movement and stress levels of premature babies in the intensive care unit. The researchers want to see if giving massages to these babies can help improve their motor skills and reduce their stress hormones, which can be important for their overall development. The study will include 30 premature infants who are between 28 and 34 weeks old and are stable in their health. To be eligible, babies need to weigh over 1000 grams and should not have any serious health issues or have undergone surgery.
If your baby is chosen to participate, they will be divided into two groups. One group will receive the massage treatment, while the other group will not. Researchers will assess the babies' motor skills and stress levels through specific tests and hormone measurements before and after the massage sessions. This study aims to gather more information on the benefits of infant massage in the intensive care setting, which could be helpful for the care of premature babies in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 28.-34. Premature infants with stable clinical conditions born between gestational weeks,
- • Babies of families whose parents can speak and understand Turkish at least one of their parents,
- • Body weight over 1000 g,
- • Premature babies are only due to non-invasive intubation,
- • Stability of the baby's vital signs
- • The baby does not have a chest tube.
- Exclusion Criteria:
- • Babies whose family consent cannot be obtained,
- • Babies born from triplet or more multiple pregnancies,
- • Babies using antiepileptic drugs,
- • Medically unstable infants,
- • Having a major anomaly,
- • Having undergone a surgical procedure.
About Mustafa Kemal University
Mustafa Kemal University is a prominent academic institution located in Hatay, Turkey, dedicated to advancing education, research, and healthcare. The university actively engages in clinical research through its affiliated medical and health sciences departments, contributing to the development of innovative treatments and healthcare solutions. With a commitment to scientific excellence and ethical standards, Mustafa Kemal University collaborates with various stakeholders to conduct rigorous clinical trials that aim to enhance patient care and improve health outcomes. Their research initiatives are designed to foster knowledge translation and promote evidence-based practices within the medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hatay, Antakya, Turkey
Hatay, Antakya, Turkey
Patients applied
Trial Officials
Sabiha bezgin
Study Director
Hatay Mustafa Kemal University, Faculty of Health Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported